January 25, 2018 / 10:17 PM / a year ago

Allergan wins last-minute halt of Asacol antitrust trial

Allergan PLC on Thursday won its last-minute bid at a federal appeals court to delay a trial set for next week in a class action lawsuit claiming it suppressed generic competition for its ulcerative colitis drug Asacol.

The 1st U.S. Circuit Court of Appeals in Boston ordered lower-court proceedings in the case be put on hold while it reviews a judge’s decision to certify a class of health plans and other indirect drug purchasers.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2GhrXxv

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below